Emöd J, Joó I
WHO Collaborating Centre for Reference and Research on Bacterial Vaccines, Human Institute for Serobacteriological Production and Research, Budapest, Hungary.
Acta Microbiol Hung. 1990;37(2):187-92.
The nonspecific resistance-enhancing activity of zymosan on experimental bacterial (Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Serratia marcescens and Staphylococcus aureus) infections was investigated. Zymosan, being of very low toxicity, significantly enhanced nonspecific resistance to the above bacteria. The enhancement was the most pronounced 2 to 5 days after zymosan treatment.
研究了酵母聚糖对实验性细菌（大肠杆菌、肺炎克雷伯菌、奇异变形杆菌、铜绿假单胞菌、黏质沙雷氏菌和金黄色葡萄球菌）感染的非特异性抵抗力增强活性。酵母聚糖毒性极低，能显著增强对上述细菌的非特异性抵抗力。在酵母聚糖处理后2至5天，这种增强最为明显。
